Oncology Research and Treatment

Journal Abbreviation: Oncol Res Treat
ISSN: 2296-5270
eISSN: 2296-5262
Publisher: Karger Publishers

Publications (236)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

The DETECT Study Concept - Metastatic breast cancer and circulating tumor cells (2016) Schramm A, Friedl T, Rack B, Trapp E, Fasching P, Taran FA, Hartkopf A, et al. Conference contribution TREAT CTC: An innovative therapy approach to eliminate circulating tumor cells (CTCs) (2016) Tzschaschel M, Trapp E, Rack B, Messina C, Mueller V, Fehm T, Janni W, et al. Conference contribution Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) Janning M, Mueller , Vettorazzi E, Cubas-Cordova M, Gensch , Ben Batalla , Eulenburg ZC, et al. Conference contribution Tumor infiltrating cells - cell-to-cell distances enable differentiation between functionally active and suppressed inflammatory cells (2016) Distel L, Nagl S, Fietkau R, Haas M Conference contribution The Treatment Reality of Octogenarians with Bladder Cancer in a Maximum Care Hospital (2016) Sikic D, Wach S, Taubert H, Richterstetter M, Kunath F, Lieb V, Krause S, et al. Conference contribution Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2016) Stritzelberger J, Distel T, Fietkau R, Putz F Conference contribution Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer (2016) Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmidt W, Eidtmann H, et al. Conference contribution Psychooncological counseling and treatment as part of the Comprehensive Cancer Center (CCC): Multicenter study to detect the psycho-oncological needs, indications and using (2016) Buettner-Teleaga A, Weis J, Goerling U, Hornemann B, Erim Y, Beckmann M, Senf B, et al. Conference contribution Oral cavity carcinomas as primary manifestation of telomere maintenance disorders (telomeropathies) (2016) Beier F, Schmitt K, Bouillon AS, Hasenbank C, Vankann L, Ambrosch P, Hoffmann T, et al. Conference contribution Proposal for a new M1 subclassification in colorectal carcinoma (2016) Merkel S, Weber K, Croner R, Golcher H, Göhl J, Agaimy A, Semrau S, et al. Conference contribution